Identification of novel prognostic factors focusing on clinical outcomes in patients with non‑small cell lung cancer after stereotactic body radiotherapy-Reference-Cited by-同舟云学术

Identification of novel prognostic factors focusing on clinical outcomes in patients with non‑small cell lung cancer after stereotactic body radiotherapy

Published:2022-01-11 Issue:3 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Sato Hikari¹,Ito Fumiki²,Hasegawa Kazuki¹,Saga Ryo¹,Hosokawa Yoichiro¹,Tanaka Mitsuki³,Aoki Masahiko³

Affiliation:

1. Department of Radiation Sciences, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan

2. Department of Radiological Technology, Hirosaki University School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan

3. Department of Radiation Oncology, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori 036‑8562, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference27 articles.

1. Stereotactic body radiotherapy (SBRT) for stage I lung cancer;Nagata;Jpn J Clin Oncol,2018

2. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?;Onishi;Int J Radiat Oncol Biol Phys,2011

3. Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery;Palma;Radiother Oncol,2011

4. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer in octogenarians and older: An alternative treatment;Bei;J Radiat Res,2020

5. Significant correlation between overall survival and mean lung dose in lung stereotactic body radiation therapy (SBRT);Dupic;Front Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer;Cancers;2024-09-10

2. Translational study for stereotactic body radiotherapy against non-small cell lung cancer, including oligometastases, considering cancer stem-like cells enable predicting clinical outcome from in vitro data;Radiotherapy and Oncology;2023-04